Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 4, 2007

Pfizer and pSivida Ink $165M Deal

  • Pfizer gained access to pSivida's controlled drug delivery technologies, including the Medidur™ technology in ophthalmic applications.

    Under this exclusive, worldwide CRADA, pSivida stands to earn $155 million in development and sales related milestones. Pfizer will fund the total cost of the joint research program aimed at developing products using pSivida’s technologies.

    Pfizer also reports that it invested $5 million in pSivida and plans to contribute an additional $5 million subject to certain conditions.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »